Date: May 24, 2016
Time: 10 AM PDT / 1 PM EDT
Speaker: Michael Fergusson
Behavior change and consumer engagement are top priorities for pharmaceutical companies in 2016, according to an industry-wide survey by MM&M. But pharma marketers know it’s hard to get engagement right. You see mobile demand grow daily, and you need to stay up to speed. It’s hard to engage, activate and show real impact on behavior change. You need actionable insights you can apply to your digital strategy this year.
Join Ayogo’s CEO, Michael Fergusson, on Tuesday, May 24th at 10:00 AM PDT / 1:00 PM EDT to learn how pharmaceutical marketers can target three natural phases of engagement, using digital health technology.
The evolving science of digital engagement, and how it applies to pharma marketing
How digital tools leverage the pattern of engagement as patients manage conditions and medication adherence over time, through three natural phases:
b. Medication Adherence and Behavior Change
c. Maintenance and the Long-tail of Persistence
How Behavioral Economics, Psychology and the Trajectory Model underpin digital engagement
Ways digital personalization can revolutionize your marketing
Actionable insights into digital engagement that can transform your digital strategy immediately
Don’t struggle any longer. You can offer better mobile solutions that deliver real value. Succeed in your commitment to patient-focused applications that delight, engage and deliver real change.
Registration is now closed.
An entrepreneur since 1997, a pioneering technologist with patents in the area of Human-Computer Interaction, and the creator of Ayogo’s ACUDO framework. He is a globally-recognized speaker, TedX alumni, Guest Editor – Journal of Computers and Human Behavior, one of the PharmaVoice 100 Most Inspiring People, and Ernst and Young Social Entrepreneur of the Year.